georgia, yemen, afghanistan, cyprus, india, singapore, saudi arabia, maldives, japan, united arab emirates, malaysia, china, south korea, north korea, taiwan, thailand, pakistan, mongolia, brunei, lebanon, indonesia, kyrgyzstan, syria, israel, bhutan, iran, turkey, armenia, qatar, philippines, kazakhstan, iraq, bangladesh, laos, vietnam, timor-leste, kuwait, myanmar, azerbaijan, jordan, nepal, sri lanka, uzbekistan, turkmenistan, macau, bahrain, cambodia, tajikistan
06 Jan 2026 06:31
BLA For Subcutaneous Formulation Of Leqembi® Accepted In China (menafn)
(MENAFN - PR Newswire)STOCKHOLM, Jan. 6, 2026 /PRNewswire/ -- BioArctic AB's (publ) (Nasdaq Stockhol...